Abstract
Several drugs have been associated with an increased risk of erectile dysfunction (ED). We analysed the role of pharmacological treatments on the risk of ED using data from a cross-sectional study on prevalence and risk factors for ED in the general population in Italy. A total of 2450 men aged more than 18 years were randomly identified by 143 general practioners (GP) among their registered patients and invited to a confidential interview by their GP. Patients were asked ‘about their ability to achieve and maintain an erection sufficient for satisfactory sexual performance’. If they were dissatisfied, they were defined as having ED. Out of the 2450 men identified, 440 (18%) refused to participate. The present analysis therefore includes information on 2010 men. After adjustment for related pathologies, anxiolytics and antidepressants showed insignificantly higher odds ratio (ORs, respectively, 1.7 and 2.1); antipsychotic drug use significantly increased the risk of ED (OR 9.0, 95% confidence interval, CI 1.8–44.4). Diuretics (OR 3.1, 95% CI 1.4–6.9) and anticholinergic drugs (OR 12.8, 95% CI 2.7–60.1) were associated with ED risk. No association emerged between ED and H2 antagonists, anticholesterolemic or hypoglycemic drugs. In conclusion, after taking account of related pathologies, our results suggest that men treated with antipsychotic, diuretic and anticholinergic drugs are at greater risk of ED.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
NIH Consensus Panel on Impotence. Impotence. JAMA 1993; 270: 83–90.
Parazzini F et al. Frequency and determinants of erectile dysfunction in Italy. Eur Urol 2000; 37: 43–49.
Feldman HA et al. Impotence and its medical and psychosocial correlates: results from the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.
Bortolotti A, Parazzini F, Colli E, Landoni M . The epidemiology of erectile dysfunction and its risk factors. Int J Androl 1997; 20: 323–334.
Araujo AB et al. Relation between psychosocial risk factors and incident erectile dysfunction: prospective results from the Massachusetts Male Aging Study. Am J Epidemiol 2000; 152: 533–541.
Derby CA et al. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 2000; 56: 302–306.
Miller NS, Gold MS . The human sexual response to alcohol and drugs. J Substance Abuse Treatment 1988; 5: 171–177.
Lue TF . Drug therapy: erectile dysfunction. N Engl J Med 2000; 342: 1802–1813.
Buffum J . Pharmacosexuology update: prescription drugs and sexual function. J Psychoactive Drugs 1986; 18: 97–106.
Grimm RH et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Hypertension 1997; 29: 8–14.
Nemeroff CB et al. Double-blind, placebo-controlled conparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001; 158: 906–912.
Mirone V et al. Cigarette smoking as risk factor for erectile dysfunction: results from an italian epidemiological study. Eur Urol 2002; 42: 1–4.
Balon R, Yeragani VK, Pohl R, Ramesh C . Sexual dysfunction during antidepressant treatment. J Clin Psychiatry 1993; 54: 209–212.
Greenblatt DJ, Koch-Weser J . Gynecomastia and impotence: complications of spironolactone therapy. JAMA 1973; 223: 82.
Wolfe MM . Impotence on cimetidine treatment. N Engl J Med 1979; 300: 94–96.
Collen MJ et al. Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion. Ann Intern Med 1984; 100: 52–58.
Jensen RT et al. Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states. Am J Med 1984; 77: 90–105.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ricci, E., Parazzini, F., Mirone, V. et al. Current drug use as risk factor for erectile dysfunction: results from an Italian epidemiological study. Int J Impot Res 15, 221–224 (2003). https://doi.org/10.1038/sj.ijir.3901008
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3901008
Keywords
This article is cited by
-
Prevalence of erectile dysfunction among Chinese men with type 2 diabetes mellitus
International Journal of Impotence Research (2010)
-
Cardiovascular drug use and the incidence of erectile dysfunction
International Journal of Impotence Research (2007)
-
Aging and pathogenesis of erectile dysfunction
International Journal of Impotence Research (2004)
-
Are subjects with erectile dysfunction aware of their condition? Results from a retrospective study based on an Italian free-call information service
Journal of Endocrinological Investigation (2004)